Federal Register notice: FDA classifies insulin therapy adjustment devices into Class 2 (special controls).
Federal Register notice: FDA withdraws two proposed medical device rules after determining that they are not currently considered viable candidates fo...
The HHS Inspector General recommends ways FDA can improve its policies and procedures to address medical device postmarket cybersecurity risks.
FDA says it is evaluating over 75 reports of battery shutdown and other issues with Maquet/Datascope intra-aortic balloon pumps.
FDA clears an OsteoRemedies 510(k) for the Remedy Spectrum GV Hip Spacer System and Spectrum GV Bone Cement, which are intended to provide surgeons wi...
Heron Therapeutics files an NDA for HTX-011, a long-acting, extended-release formulation of the local anesthetic bupivacaine in a fixed-dose combinati...
CDRH director Jeffrey Shuren says current cell phone radiofrequency exposure limits are acceptable to protect the public health.
FDA outlines for the House Energy and Commerce Committee its staffing levels of Port of Entry special agents tasked with stopping the flow of illicit ...